Business
Mallinckrodt to buy Questcor Pharmaceuticals
April 7, 2014
The Irish company agrees to pay $5.6 billion for Questcor, an Anaheim firm that makes drugs primarily to treat chronic autoimmune and inflammatory disorders.
Irish pharmaceutical company Mallinckrodt will pay $5.6 billion in cash and stock for Anaheim-based Questcor Pharmaceuticals Inc., a fast-growing bio-pharmaceutical firm that specializes in treating multiple sclerosis, the companies announced Monday.
Irish firm to buy fast-growing MS-drug maker Questcor for $5.6 billion
ANAHEIM — Mallinckrodt is buying Anaheim-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.2 billion.
Novartis, GSK announce multibillion-dollar overhaul of drug businesses
April 22, 2014
Pharmaceutical companies are taking a lot of reflected heat in the uproar over the 5,000% price hike for a drug needed by AIDS patients.
Sept. 25, 2015
The stock market hasn’t been this boring in years.
Jan. 18, 2017
Merger Suit Filed: Shareholders of Viratek Inc. and SPI Pharmaceuticals Inc. have filed two lawsuits in Delaware, where the companies are incorporated, seeking to block the companies’ proposed merger with ICN Pharmaceuticals Inc., which would create a $500-million company.
Aug. 5, 1994
Medicscript Inc., a pharmaceutical repackaging company based in Brea, has been acquired Summit Health Ltd., a Los Angeles-based health care company.
March 8, 1987